Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: poodle who wrote (2776)	3/17/1998 12:28:00 AM
From: poodle	Respond to of 7041

Abstract of this article (if it does exist) is almost identical to abstract of AUA 92-nd Ann. Meeting (Apr. 127,1997) (J.Urol. V.157,4,p202,Abstr.785). Excluding typo errors, main changes happen with Dr's names: some changes in authors list and no Zorgniotti, Wagner, Gwinup in new abstract (because it's article, they should be in references, not in abstract). All numbers are the same. BTW, similar remark "Further studies are required to corroborate our findings." instead of "further studies have to corroborate our results" still exists after all. Editorial comments (link in previous post) are not extremely optimistic.